Q2i – our SaaS technology, OARS+CM addresses the opioid epidemic. Our academic partnerships and NIH funded research results in cutting edge Contingency Management applications to improve outcomes for patients with SUD. Our evidence-based solutions improve treatment initiation, treatment adherence and treatment retention thus saving lives and costs to society.
